Polysome Profiling in Liver Identifies Dynamic Regulation of Endoplasmic Reticulum Translatome by Obesity and Fasting

English version České info

Obesity-associated metabolic complications are generally considered to emerge from abnormalities in carbohydrate and lipid metabolism, whereas the status of protein metabolism is not well studied. Here, we performed comparative polysome and associated transcriptional profiling analyses to study the dynamics and functional implications of endoplasmic reticulum (ER)–associated protein synthesis in the mouse liver under conditions of obesity and nutrient deprivation. We discovered that ER from livers of obese mice exhibits a general reduction in protein synthesis, and comprehensive analysis of polysome-bound transcripts revealed extensive down-regulation of protein synthesis machinery, mitochondrial components, and bile acid metabolism in the obese translatome. Nutrient availability also plays an important but distinct role in remodeling the hepatic ER translatome in lean and obese mice. Fasting in obese mice partially reversed the overall translatomic differences between lean and obese nonfasted controls, whereas fasting of the lean mice mimicked many of the translatomic changes induced by the development of obesity. The strongest examples of such regulations were the reduction in Cyp7b1 and Slco1a1, molecules involved in bile acid metabolism. Exogenous expression of either gene significantly lowered plasma glucose levels, improved hepatic steatosis, but also caused cholestasis, indicating the fine balance bile acids play in regulating metabolism and health. Together, our work defines dynamic regulation of the liver translatome by obesity and nutrient availability, and it identifies a novel role for bile acid metabolism in the pathogenesis of metabolic abnormalities associated with obesity.

Vyšlo v časopise: Polysome Profiling in Liver Identifies Dynamic Regulation of Endoplasmic Reticulum Translatome by Obesity and Fasting. PLoS Genet 8(8): e32767. doi:10.1371/journal.pgen.1002902
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002902

Souhrn

Zdroje

1. FritzGR, KnobilE (1963) In Vitro Stimulation by Insulin of Alpha-Amino-Isobutyric Acid Transport in the Absence of Protein Synthesis. Nature 200: 682.

2. KrahlME (1962) Insulin and protein synthesis in isolated tissues. Diabetes 11: 144–146.

3. ThomasG, Martin-PerezJ, SiegmannM, OttoAM (1982) The effect of serum, EGF, PGF2 alpha and insulin on S6 phosphorylation and the initiation of protein and DNA synthesis. Cell 30: 235–242.

4. GressnerAM, WoolIG (1976) Effect of experimental diabetes and insulin on phosphorylation of rat liver ribosomal protein S6. Nature 259: 148–150.

5. KimballSR, JurasinskiCV, LawrenceJCJr, JeffersonLS (1997) Insulin stimulates protein synthesis in skeletal muscle by enhancing the association of eIF-4E and eIF-4G. Am J Physiol 272: C754–759.

6. FleckA, ShepherdJ, MunroHN (1965) Protein synthesis in rat liver: influence of amino acids in diet on microsomes and polysomes. Science 150: 628–629.

7. HaraK, YonezawaK, WengQP, KozlowskiMT, BelhamC, et al. (1998) Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J Biol Chem 273: 14484–14494.

8. MaXM, BlenisJ (2009) Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol 10: 307–318.

9. HayN, SonenbergN (2004) Upstream and downstream of mTOR. Genes Dev 18: 1926–1945.

10. KimballSR, JeffersonLS (2005) Role of amino acids in the translational control of protein synthesis in mammals. Semin Cell Dev Biol 16: 21–27.

11. BolsterDR, CrozierSJ, KimballSR, JeffersonLS (2002) AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. J Biol Chem 277: 23977–23980.

12. HolcikM, SonenbergN (2005) Translational control in stress and apoptosis. Nat Rev Mol Cell Biol 6: 318–327.

13. WilliamsBR (2001) Signal integration via PKR. Sci STKE 2001: re2.

14. HardingHP, RonD (2002) Endoplasmic reticulum stress and the development of diabetes: a review. Diabetes 51 Suppl 3: S455–461.

15. ScheperGC, van der KnaapMS, ProudCG (2007) Translation matters: protein synthesis defects in inherited disease. Nat Rev Genet 8: 711–723.

16. KhamzinaL, VeilleuxA, BergeronS, MaretteA (2005) Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Endocrinology 146: 1473–1481.

17. FeligP, MarlissE, CahillGFJr (1969) Plasma amino acid levels and insulin secretion in obesity. N Engl J Med 281: 811–816.

18. HotamisligilGS (2010) Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140: 900–917.

19. JeffersonLS, LiaoWS, PeavyDE, MillerTB, AppelMC, et al. (1983) Diabetes-induced alterations in liver protein synthesis. Changes in the relative abundance of mRNAs for albumin and other plasma proteins. J Biol Chem 258: 1369–1375.

20. AndersonSR, GilgeDA, SteiberAL, PrevisSF (2008) Diet-induced obesity alters protein synthesis: tissue-specific effects in fasted versus fed mice. Metabolism 57: 347–354.

21. KentJD, KimballSR, JeffersonLS (1991) Effect of diabetes and insulin treatment of diabetic rats on total RNA, poly(A)+ RNA, and mRNA in skeletal muscle. Am J Physiol 260: C409–416.

22. GuilletC, DelcourtI, RanceM, GiraudetC, WalrandS, et al. (2009) Changes in basal and insulin and amino acid response of whole body and skeletal muscle proteins in obese men. J Clin Endocrinol Metab 94: 3044–3050.

23. PeavyDE, TaylorJM, JeffersonLS (1978) Correlation of albumin production rates and albumin mRNA levels in livers of normal, diabetic, and insulin-treated diabetic rats. Proc Natl Acad Sci U S A 75: 5879–5883.

24. KatsanosCS, MandarinoLJ (2011) Protein metabolism in human obesity: a shift in focus from whole-body to skeletal muscle. Obesity (Silver Spring) 19: 469–475.

25. MacotelaY, EmanuelliB, BangAM, EspinozaDO, BoucherJ, et al. (2011) Dietary leucine–an environmental modifier of insulin resistance acting on multiple levels of metabolism. PLoS ONE 6: e21187 doi:10.1371/journal.pone.0021187.

26. OyadomariS, HardingHP, ZhangY, OyadomariM, RonD (2008) Dephosphorylation of translation initiation factor 2alpha enhances glucose tolerance and attenuates hepatosteatosis in mice. Cell Metab 7: 520–532.

27. PyhtilaB, ZhengT, LagerPJ, KeeneJD, ReedyMC, et al. (2008) Signal sequence- and translation-independent mRNA localization to the endoplasmic reticulum. RNA 14: 445–453.

28. FuS, YangL, LiP, HofmannO, DickerL, et al. (2011) Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity. Nature 473: 528–531.

29. GregorMF, YangL, FabbriniE, MohammedBS, EagonJC, et al. (2009) Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss. Diabetes 58: 693–700.

30. OzcanU, CaoQ, YilmazE, LeeAH, IwakoshiNN, et al. (2004) Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306: 457–461.

31. Huang daW, ShermanBT, LempickiRA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44–57.

32. ChoudhuryM, JonscherKR, FriedmanJE (2011) Reduced mitochondrial function in obesity-associated fatty liver: SIRT3 takes on the fat. Aging (Albany NY) 3: 175–178.

33. HirscheyMD, ShimazuT, GoetzmanE, JingE, SchwerB, et al. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464: 121–125.

34. FritzKS, GalliganJJ, HirscheyMD, VerdinE, PetersenDR (2012) Mitochondrial acetylome analysis in a mouse model of alcohol-induced liver injury utilizing SIRT3 knockout mice. J Proteome Res 11: 1633–1643.

35. QiuX, BrownK, HirscheyMD, VerdinE, ChenD (2010) Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab 12: 662–667.

36. StilesAR, McDonaldJG, BaumanDR, RussellDW (2009) CYP7B1: one cytochrome P450, two human genetic diseases, and multiple physiological functions. J Biol Chem 284: 28485–28489.

37. WuZ, MartinKO, JavittNB, ChiangJY (1999) Structure and functions of human oxysterol 7alpha-hydroxylase cDNAs and gene CYP7B1. J Lipid Res 40: 2195–2203.

38. van de SteegE, WagenaarE, van der KruijssenCM, BurggraaffJE, de WaartDR, et al. (2010) Organic anion transporting polypeptide 1a/1b-knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs. J Clin Invest 120: 2942–2952.

39. IngoliaNT, LareauLF, WeissmanJS (2011) Ribosome profiling of mouse embryonic stem cells reveals the complexity and dynamics of mammalian proteomes. Cell 147: 789–802.

40. BrarGA, YassourM, FriedmanN, RegevA, IngoliaNT, et al. (2012) High-Resolution View of the Yeast Meiotic Program Revealed by Ribosome Profiling. Science

41. InsullWJr (2006) Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: a scientific review. South Med J 99: 257–273.

42. LefebvreP, CariouB, LienF, KuipersF, StaelsB (2009) Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev 89: 147–191.

43. HoutenSM, WatanabeM, AuwerxJ (2006) Endocrine functions of bile acids. EMBO J 25: 1419–1425.

44. WatanabeM, HoutenSM, MatakiC, ChristoffoleteMA, KimBW, et al. (2006) Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439: 484–489.

45. ThomasC, GioielloA, NoriegaL, StrehleA, OuryJ, et al. (2009) TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab 10: 167–177.

46. ClaudelT, StaelsB, KuipersF (2005) The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism. Arterioscler Thromb Vasc Biol 25: 2020–2030.

47. MaK, SahaPK, ChanL, MooreDD (2006) Farnesoid X receptor is essential for normal glucose homeostasis. J Clin Invest 116: 1102–1109.

48. CrosignaniA, Del PuppoM, LongoM, De FabianiE, CarusoD, et al. (2007) Changes in classic and alternative pathways of bile acid synthesis in chronic liver disease. Clin Chim Acta 382: 82–88.

49. VlahcevicZR, StravitzRT, HeumanDM, HylemonPB, PandakWM (1997) Quantitative estimations of the contribution of different bile acid pathways to total bile acid synthesis in the rat. Gastroenterology 113: 1949–1957.

50. ThomasC, PellicciariR, PruzanskiM, AuwerxJ, SchoonjansK (2008) Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov 7: 678–693.

51. PolsTW, NomuraM, HarachT, Lo SassoG, OosterveerMH, et al. (2011) TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading. Cell Metab 14: 747–757.

52. MogensenM, SahlinK, FernstromM, GlintborgD, VindBF, et al. (2007) Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 56: 1592–1599.

53. MoothaVK, LindgrenCM, ErikssonKF, SubramanianA, SihagS, et al. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34: 267–273.

54. TannerCJ, BarakatHA, DohmGL, PoriesWJ, MacDonaldKG, et al. (2002) Muscle fiber type is associated with obesity and weight loss. Am J Physiol Endocrinol Metab 282: E1191–1196.

55. KimballSR, JeffersonLS, FaddenP, HaysteadTA, LawrenceJCJr (1996) Insulin and diabetes cause reciprocal changes in the association of eIF-4E and PHAS-I in rat skeletal muscle. Am J Physiol 270: C705–709.

56. PainVM, GarlickPJ (1974) Effect of streptozotocin diabetes and insulin treatment on the rate of protein synthesis in tissues of the rat in vivo. J Biol Chem 249: 4510–4514.

57. RamseyJC, SteeleWJ (1979) A method for visualizing and quantifying the total complement of free and membrane-bound ribosomes in rat liver. Anal Biochem 92: 305–313.

58. SaeedAI, BhagabatiNK, BraistedJC, LiangW, SharovV, et al. (2006) TM4 microarray software suite. Methods Enzymol 411: 134–193.

59. WuM, NeilsonA, SwiftAL, MoranR, TamagnineJ, et al. (2007) Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am J Physiol Cell Physiol 292: C125–136.

60. FuruhashiM, TuncmanG, GorgunCZ, MakowskiL, AtsumiG, et al. (2007) Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature 447: 959–965.